ConductScience.org, home

Trial · NCT03367156

Results by group16

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 7 Average IntensityDexamethasone-1.695% Confidence Interval -2.0 to -1.2score on a scale
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 7 Average IntensityPlacebo-1.695% Confidence Interval -2.3 to -0.9score on a scale
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 14 Average IntensityDexamethasone-1.895% Confidence Interval -2.2 to -1.3score on a scale
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 14 Average IntensityPlacebo-1.995% Confidence Interval -2.6 to -1.2score on a scale
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 7 Average UnpleasantnessDexamethasone-1.895% Confidence Interval -2.3 to -1.2score on a scale
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 7 Average UnpleasantnessPlacebo-2.295% Confidence Interval -3.2 to -1.2score on a scale
Change in Edmonton Symptom Assessment Scale (ESAS) Dyspnea Score Between Baseline and Day 7Dexamethasone-1Inter-Quartile Range -3 to -1score on a scale
Change in Edmonton Symptom Assessment Scale (ESAS) Dyspnea Score Between Baseline and Day 7Placebo-1.5Inter-Quartile Range -3 to 0score on a scale
Change in European Organization for Research and Treatment of Cancer-Quality of Life (EORTC QLQ-C30) Dyspnea Score Between Baseline and Day 7Dexamethasone-33.3Inter-Quartile Range -33.3 to 0score on a scale
Change in European Organization for Research and Treatment of Cancer-Quality of Life (EORTC QLQ-C30) Dyspnea Score Between Baseline and Day 7Placebo-33.3Inter-Quartile Range -33.3 to 0score on a scale
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 14 Average UnpleasantnessDexamethasone-1.7Inter-Quartile Range -2.4 to -1.1score on a scale
Change in Dyspnea Numeric Score Over the Past 24 Hours for Baseline and Day 14 Average UnpleasantnessPlacebo-2.3Inter-Quartile Range -3.4 to -1.3score on a scale
Change in Edmonton Symptom Assessment Scale (ESAS) Dyspnea Score Between Baseline and Day 14Dexamethasone-2Inter-Quartile Range -3 to 0score on a scale
Change in Edmonton Symptom Assessment Scale (ESAS) Dyspnea Score Between Baseline and Day 14Placebo-1Inter-Quartile Range -4 to 0score on a scale
Change in European Organization for Research and Treatment of Cancer Quality of Life (EORTC) Dyspnea Score Between Baseline and Day 14Dexamethasone-33.3Inter-Quartile Range -33.3 to 0score on a scale
Change in European Organization for Research and Treatment of Cancer Quality of Life (EORTC) Dyspnea Score Between Baseline and Day 14Placebo-33.3Inter-Quartile Range -33.3 to 0score on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03367156/results